Novartis’ Ianalumab granted FDA orphan designation
Ianalumab, for the treatment of primary immune thrombocytopenia, was granted FDA orphan designation, according to a post on the ...
Novartis AG (NOVN) Gets a Buy from Deutsche Bank
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novartis AG (NOVN – Research Report) yesterday and set a price target of ...
MM&M2d
Novartis buys back Anthos Therapeutics for up to $3.1B
Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...
Today5d
Walmart gets a new logo and people are talking. Here's why
Walmart’s latest brand and logo update has left some social media ... In a statement, William White, senior vice president and chief marketing officer, Walmart U.S, said, in part, “This ...